SecBot SecBot
Insider Cluster (4 insiders) ·Filed Jun 15, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 4 insiders, $1.1M total
Actionable Insight • Neutral

Insider sales are negligible relative to market cap and likely reflect routine portfolio diversification. No actionable signal for traders.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$67.71
T+0 close · Jun 15, 2026 · via day close
Latest settled
+35.36%
T+60 · $91.65
Vs SPY
+34.36%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 16 $67.71entry
  2. T+1 · 5mo ago +4.68%α +5.93% · $70.88
  3. T+5 · 5mo ago +23.17%α +25.40% · $83.40
  4. T+20 · 4mo ago +29.18%α +28.98% · $87.47
  5. T+60 · 2mo ago +35.36%α +34.36% · $91.65
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a Director) sold a total of ~$2.67M in open-market transactions over a 5-day window. The sales represent only 0.06% of the company's $4.2B market cap, making them immaterial and likely routine portfolio diversification.

Key Financial Metrics

Direction
selling
Total Value
$2.7M
Insiders
4

Key Facts

  • CEO Lawrence Klein sold 1,729 shares for ~$120K on June 15.
  • COO Laura Sandler sold 600 shares for ~$42K on June 15.
  • General Counsel Paul Quinlan sold 733 shares for ~$51K on June 15.
  • Director Carl Dambkowski sold 35,000 shares (two transactions) for ~$2.45M on June 11-12.
  • Total insider sales of ~$2.67M are 0.06% of ORKA's $4.2B market cap.

Financial Impact

Total insider sales of $2.67M represent 0.06% of market cap, immaterial.

insider selling

Risk Factors

  • No material risk from this cluster; sales are too small to indicate a bearish view.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1781564045890

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 9h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026